Hospira Cisplatin Injection 50mg/50mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira cisplatin injection 50mg/50ml vial

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; mannitol - cancer chemotherapeutic drug - details of indications do not appear in the leaflet as exported from hospira australia

Hospira Cisplatin Injection 100 mg/100 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira cisplatin injection 100 mg/100 ml vial

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections - cancer chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from hospira australia

Hospira Bleomycin 15,000 IU Powder for Injection, vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira bleomycin 15,000 iu powder for injection, vial

hospira australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: - squamous cell carcinoma affecting the mouth, nasopharynx, larynx, paranasal sinuses, oesophagus, external genitalia, cervix or skin. hodgkin's disease and other malignant lymphomas including mycosis fungoides. testicular teratoma. malignant effusions of the serous cavities. metastatic melanoma and the carcinomas of the thyroid, lung and bladder.

Hospira Atracurium Besilate 10 mg/mL Injection 250 mg/25 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira atracurium besilate 10 mg/ml injection 250 mg/25 ml vial

hospira australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - atracurium besilate injection is indicated as an adjunct to general anaesthesia during surgery to relax skeletal muscles, and to facilitate endotracheal intubation and mechanical ventilation. it is also indicated to facilitate mechanical ventilation in intensive care unit (icu) patients.

HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira levetiracetam concentrate for iv infusion levetiracetam 500 mg/5 ml concentrate for infusion vial

pfizer australia pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: nitrogen; sodium acetate trihydrate; sodium chloride; glacial acetic acid; water for injections - hospira? levetiracetam concentrate for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible. levetiracetam is indicated for: use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation; monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy and add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy.

HOSPIRA VINCRISTINE SULFATE 5mg/5mL Injection Vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vincristine sulfate 5mg/5ml injection vial

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sulfuric acid; sodium hydroxide - not applicable - to be used as part of the liposome injection kit. details are owned by the licence holder, not hospira.